Percutaneous coronary intervention results in acute increases in native and oxidized lipoprotein(a) in patients with acute coronary syndrome and stable coronary artery disease

Clinical Biochemistry

Volumn 43, Issue 13-14, 2010, Pages 1107-1111

  Wang, Jun jun ^a   Zhang, Chun ni ^a   Han, Ai zhong ^a   Gong, Jian bin ^b   Li, Ke ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b JINLING HOSPITAL   (China)

Author keywords

Acute coronary syndrome; Angioplasty; Atherosclerosis; Coronary artery disease; Lipoprotein(a); Oxidized lipoprotein

Indexed keywords

AUTOANTIBODY; LIPOPROTEIN A; MONOCLONAL ANTIBODY;

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ANTIGEN ANTIBODY COMPLEX; ARTICLE; ASSAY; ATHEROSCLEROSIS; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY, BALLOON, CORONARY; ANTIGEN-ANTIBODY COMPLEX; AUTOANTIBODIES; CORONARY ARTERY DISEASE; FEMALE; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; OXIDATION-REDUCTION;

EID: 77956179930     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.06.019     Document Type: Article

References (35)

1. Scanu A.M., Lawn R.M., Berg K. Lipoprotein(a) and atherosclerosis. Ann Intern Med 1991, 115:209-218.
2. Dahlen G., Guyton J.R., Attar M., Farmer J.A., Kautz J.A., Gotto A.M. Association of plasma concentrations of lipoprotein(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986, 74:758-765.
3. Terres W., Tatsis E., Pfalzer B., Beil F.U., Beisiegel U., Hamm C.W. Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a). Circulation 1995, 91:948-950.
4. Zioncheck T.F., Powell L.M., Rice G.C., Eaton D.L., Lawn R.M. Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages. J Clin Invest 1991, 87:767-771.
5. Haberland M.E., Fless G.M., Scanu A.M., Fogelman A.M. Malondialdehyde modification of lipoprotein(a) produces avid uptake by human monocytemacrophages. J Biol Chem 1992, 267:4143-4151.
6. Mahmoud S.R., Periasamy S., Demetrios S.S. Oxidized lipoprotein(a) induces cell adhesion molecule Mac-1 (CD 11b) and enhances adhesion of the monocytie cell line U937 to cultured endothelial cells. Atherosclerosis 1996, 123:103-113.
7. Naruszewicze M., Giroux L.M., Davignon J. Oxidative modification of Lp(a) causes changes in the structure and biological properties of apo(a). Chem Phys Lipids 1994, 67-68:167-174.
8. Yamada S., Morishita R., Nakamura S., et al. Development of antibody against epitope of lipoprotein(a) modified by oxidation: evaluation of new enzyme-linked immunosorbent assay for oxidized lipoprotein(a). Circulation 2000, 102:1639-1644.
9. Podrez E.A., O'Neil J., Salomon R.G., Schreiber M.J., Hoff H.F. Measurement of oxidation in plasma Lp(a) in CAPD patients using a novel ELISA. Kidney Int 1998, 54:637-645.
10. Wang J., Niu D., Meng Y., Han A., Li K., Zhang C. Plasma oxidized lipoprotein(a) and its immune complexes are present in newborns and children. Clin Chim Acta 2009, 407:1-5.
11. Wang J.J., Zhang C.N., Meng Y., Han AZ., Gong J.B., Li K. Elevated levels of oxidized lipoprotein(a) are associated with the presence and severity of acute coronary syndromes. Clin Chim Acta 2009, 408:79-82.
12. Wang J.J., Han A.Z., Meng Y., et al. Measurement of oxidized lipoprotein (a) in patients with acute coronary syndromes and stable coronary artery disease by 2 ELISAs: using different capture antibody against oxidized lipoprotein (a) or oxidized LDL. Clin Biochem 2010, 43:571-575.
13. Wang J.J., Hu B., Kong L.T., Cai H., Zhang C.N. Native, oxidized lipoprotein(a) and lipoprotein(a) immune complex in patients with active and inactive rheumatoid arthritis: plasma concentrations and relationship to inflammation. Clin Chim Acta 2008, 390:67-71.
14. Romero F.I., Atsumi T., Tinahones F.J., et al. Autoantibodies against malondialdehyde modified lipoprotein(a) in antiphospholipid syndrome. Arthritis Rheum 1999, 42:2606-2611.
15. Wang J.J., Qiang H.J., Zhang C.N., Liu X.C., Chen D.N., Wang S.N. Detection of IgG-bound lipoprotein(a) immune complexes in patients with coronary heart disease. Clin Chim Acta 2003, 327:115-122.
16. Wang J.J., Zhang C.N., Chen D.N., Liu X.C., Feng X.M. Lipoprotein(a) and its immune complexes concentrations in subjects with various dyslipidaemias. Clin Biochem 2004, 37:710-713.
17. Hoff H.F., O'Neil J., Yashiro A. Partial characterization of lipoproteins containing apo(a) in human atherosclerotic lesions. J Lipid Res 1993, 34:789-798.
18. Holvoet P., Mertens A., Verhamme P., et al. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2001, 21:844-848.
19. Ehara S., Ueda M., Naruko T., et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 2001, 103:1955-1960.
20. Nishi K., Itabe H., Uno M., et al. Oxidized LDL in carotid plaques and plasma associates with plaque instability. Arterioscler Thromb Vasc Biol 2002, 22:1649-1654.
21. Tsimikas S., Bergmark C., Beyer R.W., et al. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. J Am Coll Cardiol 2003, 41:360-370.
22. Anselmi M., Garbin U., Agostoni P., et al. Plasma levels of oxidized-low-density lipoproteins are higher in patients with unstable angina and correlated with angiographic coronary complex plaques. Atherosclerosis 2006, 185:114-120.
23. Edelstein C., Pfaffinger D., Hinman J., et al. Lysine-phosphatidylcholine adducts in kringle V impart unique immunological and potential proinflammatory properties to human apolipoprotein (a). J Biol Chem 2003, 278:52841-52847.
24. Tsimikas S., Brilakis E.S., Miller E.R., et al. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med 2005, 353:46-57.
25. Tsimikas S., Kiechl S., Willeit J., et al. Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease. Five-year prospective results from the Bruneck study. J Am Coll Cardiol 2006, 47:2219-2228.
26. Tsimikas S., Lau H.K., Han K.R., et al. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a). Short-term and long-term immunologic responses to oxidized low-density lipoprotein. Circulation 2004, 109:3164-3170.
27. Wang J.J., Zhuang Y.Y., Yao X.D. Quantitation of plasminogen epitopes of serum lipoprotein(a) by sandwich enzyme linked immunosorbent assay. Clin Chim Acta 1997, 265:121-130.
28. Wang J.J., Zhang C.N., Gong J.B., et al. Development of new enzyme-linked immunosorbent assay for oxidized lipoprotein(a) by using purified human oxidized lipoprotein(a) autoantibodies as capture antibody. Clin Chim Acta 2007, 385:73-78.
29. Tsimikas S. Oxidative biomarkers in the diagnosis and prognosis of cardiovascular disease. Am J Cardiol 2006, 98:9-17.
30. Holvoet P., Stassen J.M., Van Cleemput J., Collen D., Vanhaecke J. Correlation between oxidized low density lipoproteins and coronary artery disease in heart transplant patients. Arterioscler Thromb Vasc Biol 1998, 18:100-107.
31. Holvoet P., Theilmeier G., Shivalkar B., Flameng W., Collen D. LDL hypercholesterolemia is associated with accumulation of oxidized LDL, atherosclerotic plaque growth, and compensatory vessel enlargement in coronary arteries of miniature pigs. Arterioscler Thromb Vasc Biol 1998, 18:415-422.
32. Prati F., Pawlowski T., Gil R., et al. Stenting of culprit lesions in unstable angina leads to a marked reduction in plaque burden: a major role of plaque embolization? A serial intravascular ultrasound study. Circulation 2003, 107:2320-2325.
33. Buffon A., Santini S.A., Ramazzotti V., et al. Large, sustained cardiac lipid peroxidation and reduced antioxidant capacity in the coronary circulation after brief episodes of myocardial ischemia. J Am Coll Cardiol 2000, 35:633-639.
34. Maeda S., Abe A., Seishima M., Makino K., Noma A., Kawade M. Transient changes of serum lipoprotein(a) as an acute phase protein. Atherosclerosis 1989, 78:145-150.
35. Wade D.P., Clarke J.G., Lindahl G.E., et al. 5' Control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family. Proc Natl Acad Sci USA 1993, 90:1369-1373.